TITLE

On the Threshold of Systems Biology

AUTHOR(S)
Russell, John
PUB. DATE
September 2006
SOURCE
Pharma DD: Tracking Discovery & Development;Sep/Oct2006, Vol. 1 Issue 2, p6
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article discusses issues related to systems biology. Meeting increasing demand inside Pfizer is being faced by David de Graaf, director of systems biology at Pfizer, and work partner Bruce Gomes since the deployment of systems biology at the company. Efforts of systems biology in general are attempting to define all knowable knowledge of biological systems via a variety of platform technologies according to Ajay Royyuru, senior manager of computational biology at the Watson laboratory of IBM Research.
ACCESSION #
23475273

 

Related Articles

  • Where Should Systems Bio Reside? De Graaf, David; Hill, Colin // Bio-IT World;Feb2006, Vol. 5 Issue 1, p32 

    Presents the statements issued by two executives of pharmaceutical firms on their investments in systems biology. David de Graaf, director of systems biology at Pfizer; Colin Hill, co-founder and CEO of Gene Network Sciences.

  • PowerPoints…NOT! De Graaf, David // Bio-IT World;Feb2006, Vol. 5 Issue 1, p32 

    Presents a statement issued by David de Graaf, director of systems biology at Pfizer, on the state of computational modeling of biological systems. Disadvantage of PowerPoint presentations.

  • On the Threshold of Systems Biology. Russell, John // Bio-IT World;Sep2006, Vol. 5 Issue 7, p42 

    The article focuses on systems biology. It mentions that the first director of systems biology for Pfizer is David de Graaf to help the company better understand its potential in systems biology and to act as a medium for the technology to researchers. It is believed that systems biology will...

  • Is Pharma Ready to Bet On Modeling?  // Bio-IT World;Feb2006, Vol. 5 Issue 1, p30 

    Presents views of several executives of pharmaceutical firms, on the state of computational modeling of biological systems. David de Graaf, director of systems biology at Pfizer; Colin Hill, co-founder and CEO of Gene Network Sciences; Alex Bangs, co-founder and CTO of Entelos.

  • People in the News.  // Medical Device Daily;6/2/2010, Vol. 14 Issue 105, p10 

    The article announces the appointment of David de Graaf as chief scientific officer of Genstruct.

  • Informatics Cornucopia. Russell, John // Bio-IT World;Sep2006, Vol. 5 Issue 7, p19 

    The article highlights the Predictive Informatics session at the Drug Discovery Technology & Department World Congresses. A glimpse into the tools of Novartis for predicting toxicology has been provided by computational chemist William Egan. Bruce Gomes, head of modeling at the systems biology...

  • de Graaf on scientific board for SIB Swiss.  // Medical Device Daily;8/16/2011, Vol. 15 Issue 153, p7 

    The article announces the appointment of David de Graaf, chief executive officer (CEO) of Selventa, to the scientific advisory board of the SIB Swiss Institute of Bioinformatics.

  • Experts on Call.  // PharmaGenomics;Nov/Dec2002, Vol. 2 Issue 6, p50 

    Features additional members to the editorial advisory board of the 'PharmaGenomics' magazine. Günther Bonn; Gordon W. Logan; Ajay K. Royyuru.

  • What's New at Big Blue? Greeley, Michael A. // Bio-IT World;Mar2005, Vol. 4 Issue 3, p14 

    Presents an interview with Ajay Royyuru, head of the Computational Biology Center at Thomas J. Watson Research Center, regarding applications of the Blue Gene supercomputer and industrialized approach to commercialize the biotechnology field. Developments in bioinformatics; Concern about the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics